Safety and Efficacy of Sacubitril/Valsartan in Patients With a Failing Systemic Right Ventricle: A Prospective Single-Center Study.

Flavia Fusco Giancarlo ScognamiglioAssunta MerolaAngela IannuzziMichela PalmaNicola Grimaldi Berardo Sarubbi

Published in: Circulation. Heart failure (2022)

Our data showed that sacubitril/valsartan is well tolerated and is associated with systemic right ventricle remodeling and improved systolic function as well as improved clinical status, supporting its use in this complex population.

Keyphrases

pulmonary artery
ejection fraction
pulmonary hypertension
mitral valve
blood pressure
left ventricular
electronic health record
big data
coronary artery
pulmonary arterial hypertension
machine learning